{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:27:35Z","timestamp":1762543655291,"version":"3.40.5"},"reference-count":31,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T00:00:00Z","timestamp":1653436800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:sec id=\"sec001\"><jats:title>Background<\/jats:title><jats:p>Persons living with diagnosed HIV (PLWDH) are at increased risk for severe illness due to COVID-19. The degree to which this due to HIV infection, comorbidities, or other factors remains unclear.<\/jats:p><\/jats:sec><jats:sec id=\"sec002\"><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective matched cohort study of individuals hospitalized with COVID-19 in New York State between March and June 2020, during the first wave of the pandemic, to compare outcomes among 853 PLWDH and 1,621 persons without diagnosed HIV (controls). We reviewed medical records to compare sociodemographic and clinical characteristics at admission, comorbidities, and clinical outcomes between PLWDH and controls. HIV-related characteristics were evaluated among PLWDH.<\/jats:p><\/jats:sec><jats:sec id=\"sec003\"><jats:title>Results<\/jats:title><jats:p>PLWDH were significantly more likely to have cardiovascular (matched prevalence-ratio [mPR], 1.22 [95% CI, 1.07\u20131.40]), chronic liver (mPR, 6.71 [95% CI, 4.75\u20139.48]), chronic lung (mPR, 1.76 [95% CI, 1.40\u20132.21]), and renal diseases (mPR, 1.77 [95% CI, 1.50\u20132.09]). PLWDH were less likely to have elevated inflammatory markers upon hospitalization. Relative to controls, PLWDH were 15% less likely to require mechanical ventilation or extracorporeal membrane oxygenation (ECMO) and 15% less likely to require admission to the intensive care unit. No significant differences were found in in-hospital mortality. PLWDH on tenofovir-containing regimens were significantly less likely to require mechanical ventilation or ECMO (risk-ratio [RR], 0.73 [95% CI, 0.55\u20130.96]) and to die (RR, 0.74 [95% CI, 0.57\u20130.96]) than PLWDH on non-tenofovir-containing regimens.<\/jats:p><\/jats:sec><jats:sec id=\"sec004\"><jats:title>Conclusions<\/jats:title><jats:p>While hospitalized PLWDH and controls had similar likelihood of in-hospital death, chronic disease profiles and degree of inflammation upon hospitalization differed. This may signal different mechanisms leading to severe COVID-19.<\/jats:p><\/jats:sec>","DOI":"10.1371\/journal.pone.0268978","type":"journal-article","created":{"date-parts":[[2022,5,25]],"date-time":"2022-05-25T17:32:20Z","timestamp":1653499940000},"page":"e0268978","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["Factors associated with SARS-CoV-2-related hospital outcomes among and between persons living with and without diagnosed HIV infection in New York State"],"prefix":"10.1371","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3908-4136","authenticated-orcid":true,"given":"Elizabeth M.","family":"Rosenthal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli S.","family":"Rosenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Patterson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy P.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jack","family":"DeHovitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5319-2689","authenticated-orcid":true,"given":"Tomoko","family":"Udo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepa T.","family":"Rajulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hart-Malloy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tesoriero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2022,5,25]]},"reference":[{"key":"pone.0268978.ref001","unstructured":"Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2020. Hyattsville, MD: 2021."},{"key":"pone.0268978.ref002","unstructured":"Centers for Disease Control and Prevention. People with certain medical conditions 2021 [updated May 13, 2021; cited 2021 December 22]. from: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/need-extra-precautions\/people-with-medical-conditions.html."},{"issue":"2","key":"pone.0268978.ref003","doi-asserted-by":"crossref","first-page":"e2037069","DOI":"10.1001\/jamanetworkopen.2020.37069","article-title":"COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State","volume":"4","author":"JM Tesoriero","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"7","key":"pone.0268978.ref004","doi-asserted-by":"crossref","first-page":"e25573","DOI":"10.1002\/jia2.25573","article-title":"SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States","volume":"23","author":"KM Byrd","year":"2020","journal-title":"J Int AIDS Soc"},{"issue":"16","key":"pone.0268978.ref005","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1093\/cid\/ciaa579","article-title":"Clinical Features and Outcomes of Patients With Human Immunodeficiency Virus With COVID-19","volume":"71","author":"C Gervasoni","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0268978.ref006","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s15010-020-01438-z","article-title":"COVID-19 in people living with human immunodeficiency virus: a case series of 33 patients","volume":"48","author":"G H\u00e4rter","year":"2020","journal-title":"Infection"},{"issue":"3","key":"pone.0268978.ref007","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/infdis\/jiaa380","article-title":"Clinical Outcomes and Immunologic Characteristics of Coronavirus Disease 2019 in People With Human Immunodeficiency Virus","volume":"223","author":"HE Ho","year":"2021","journal-title":"J Infect Dis"},{"issue":"1","key":"pone.0268978.ref008","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1097\/QAI.0000000000002423","article-title":"Outcomes Among HIV-Positive Patients Hospitalized With COVID-19","volume":"85","author":"S Karmen-Tuohy","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"2","key":"pone.0268978.ref009","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/hiv.13174","article-title":"Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study)","volume":"23","author":"MJ Lee","year":"2022","journal-title":"HIV Med"},{"issue":"16","key":"pone.0268978.ref010","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1093\/cid\/ciaa635","article-title":"Clinical Characteristics and Outcomes in People Living With Human Immunodeficiency Virus Hospitalized for Coronavirus Disease 2019","volume":"71","author":"N Shalev","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pone.0268978.ref011","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1093\/cid\/ciaa880","article-title":"Coronavirus 2019 and People Living With Human Immunodeficiency Virus: Outcomes for Hospitalized Patients in New York City","volume":"71","author":"K Sigel","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"8","key":"pone.0268978.ref012","doi-asserted-by":"crossref","first-page":"ofaa327","DOI":"10.1093\/ofid\/ofaa327","article-title":"COVID-19 in Hospitalized Adults With HIV","volume":"7","author":"K Stoeckle","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"5","key":"pone.0268978.ref013","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1016\/S2352-3018(21)00070-9","article-title":"Overview of SARS-CoV-2 infection in adults living with HIV","volume":"8","author":"J Ambrosioni","year":"2021","journal-title":"Lancet HIV"},{"issue":"1","key":"pone.0268978.ref014","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/QAI.0000000000002414","article-title":"Intersecting Pandemics: Impact of SARS-CoV-2 (COVID-19) Protective Behaviors on People Living With HIV, Atlanta, Georgia","volume":"85","author":"SC Kalichman","year":"2020","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"pone.0268978.ref015","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1097\/QAD.0000000000002607","article-title":"Disproportionate burden of coronavirus disease 2019 among racial minorities and those in congregate settings among a large cohort of people with HIV","volume":"34","author":"EA Meyerowitz","year":"2020","journal-title":"AIDS"},{"key":"pone.0268978.ref016","article-title":"COVID-19 infection among people with HIV in New York City: A population-level analysis of linked surveillance data","author":"SL Braunstein","year":"2020","journal-title":"Clin Infect Dis"},{"key":"pone.0268978.ref017","article-title":"HIV\/AIDS in the Era of COVID-19: A Juxtaposition of Two Pandemics","author":"RW Eisinger","year":"2021","journal-title":"J Infect Dis"},{"key":"pone.0268978.ref018","unstructured":"World Health Organization. Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection. 2021 [cited 2021 December 22]. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-Clinical-HIV-2021.1."},{"issue":"7","key":"pone.0268978.ref019","doi-asserted-by":"crossref","first-page":"e1964","DOI":"10.1093\/cid\/ciaa1339","article-title":"Characteristics, Comorbidities, and Outcomes in a Multicenter Registry of Patients With Human Immunodeficiency Virus and Coronavirus Disease 2019","volume":"73","author":"D Dandachi","year":"2021","journal-title":"Clin Infect Dis"},{"issue":"5","key":"pone.0268978.ref020","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/hiv.13037","article-title":"Immune deficiency is a risk factor for severe COVID-19 in people living with HIV","volume":"22","author":"C Hoffmann","year":"2021","journal-title":"HIV Med"},{"issue":"11","key":"pone.0268978.ref021","doi-asserted-by":"crossref","first-page":"e701","DOI":"10.1016\/S2352-3018(21)00240-X","article-title":"Sociodemographic, clinical, and immunological factors associated with SARS-CoV-2 diagnosis and severe COVID-19 outcomes in people living with HIV: a retrospective cohort study","volume":"8","author":"DK Nomah","year":"2021","journal-title":"Lancet HIV"},{"key":"pone.0268978.ref022","doi-asserted-by":"crossref","unstructured":"Sun J, Patel RC, Zheng Q, Madhira V, Olex AL, Islam JY, et al. COVID-19 Disease Severity among People with HIV Infection or Solid Organ Transplant in the United States: A Nationally-representative, Multicenter, Observational Cohort Study. medRxiv [Preprint]. 2021. Epub 20210728.","DOI":"10.1101\/2021.07.26.21261028"},{"issue":"11","key":"pone.0268978.ref023","doi-asserted-by":"crossref","first-page":"e690","DOI":"10.1016\/S2352-3018(21)00239-3","article-title":"Associations between HIV infection and clinical spectrum of COVID-19: a population level analysis based on US National COVID Cohort Collaborative (N3C) data","volume":"8","author":"X Yang","year":"2021","journal-title":"Lancet HIV"},{"issue":"7","key":"pone.0268978.ref024","doi-asserted-by":"crossref","first-page":"536","DOI":"10.7326\/M20-3689","article-title":"Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy: A Cohort Study","volume":"173","author":"J Del Amo","year":"2020","journal-title":"Ann Intern Med"},{"key":"pone.0268978.ref025","unstructured":"New York State Department of Health. Part 63: HIV\/AIDS testing, reporting and confidentiality of HIV-related information [cited 2021 December 22]. https:\/\/health.ny.gov\/professionals\/reportable_diseases\/eclrs\/hiv\/index.htm."},{"key":"pone.0268978.ref026","volume-title":"Modern Epidemiology","author":"TL Lash","year":"2021","edition":"4"},{"issue":"12","key":"pone.0268978.ref027","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1089\/apc.2021.0124","article-title":"HIV Diagnosis and the Clinical Course of COVID-19 Among Patients Seeking Care Within the New York City Public Hospital System During the Initial Pandemic Peak","volume":"35","author":"E Kaplan-Lewis","year":"2021","journal-title":"AIDS Patient Care STDS"},{"key":"pone.0268978.ref028","article-title":"Outcomes of COVID-19 related hospitalization among people with HIV in the ISARIC WHO Clinical Characterization Protocol (UK): a prospective observational study","author":"AM Geretti","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"11","key":"pone.0268978.ref029","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1016\/j.cmi.2021.06.023","article-title":"Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort","volume":"27","author":"J Berenguer","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"pone.0268978.ref030","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1097\/QAD.0000000000002836","article-title":"Risk of adverse coronavirus disease 2019 outcomes for people living with HIV","volume":"35","author":"MM Mellor","year":"2021","journal-title":"AIDS"},{"key":"pone.0268978.ref031","unstructured":"New York State Department of Health. Uninsured Care Programs 2021 [cited 2021 December 22]. https:\/\/www.health.ny.gov\/diseases\/aids\/general\/resources\/adap\/."}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268978","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T06:10:37Z","timestamp":1700633437000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0268978"}},"subtitle":[],"editor":[{"given":"Muhammad Tarek","family":"Abdel Ghafar","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,25]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,5,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0268978","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2022,5,25]]}}}